ProfileGDS4718 / 1570447_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 46% 45% 46% 45% 44% 47% 47% 49% 44% 51% 48% 45% 45% 46% 49% 43% 45% 43% 46% 40% 48% 46% 46% 46% 46% 47% 46% 46% 42% 49% 45% 47% 47% 49% 48% 44% 45% 41% 49% 46% 47% 48% 45% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3247746
GSM549102patient 115, normal, homogenized [OPG study]5.2605145
GSM549104patient 119, normal, homogenized [OPG study]5.3086946
GSM549108patient 138, normal, homogenized [OPG study]5.3062845
GSM549119patient 077, normal, homogenized [OPG study]5.1809844
GSM549133patient 032, cancer, homogenized [OPG study]5.2742347
GSM549139patient 042, cancer, homogenized [OPG study]5.3240647
GSM549099patient 107, normal, homogenized [OPG study]5.4610449
GSM549109patient 139, normal, homogenized [OPG study]5.2043344
GSM549110patient 046, normal, homogenized [OPG study]5.5976751
GSM549114patient 063, normal, homogenized [OPG study]5.3551248
GSM549122patient 082, normal, homogenized [OPG study]5.2676545
GSM549134patient 033, cancer, homogenized [OPG study]5.2374445
GSM549136patient 036, cancer, homogenized [OPG study]5.2590546
GSM549140patient 044, cancer, homogenized [OPG study]5.4163849
GSM549111patient 047, normal, homogenized [OPG study]5.1364543
GSM549113patient 057, normal, homogenized [OPG study]5.172245
GSM549132patient 031, cancer, homogenized [OPG study]5.1474543
GSM549137patient 038, cancer, homogenized [OPG study]5.2752846
GSM549142patient 047, cancer, homogenized [OPG study]5.124940
GSM549100patient 110, normal, homogenized [OPG study]5.4185948
GSM549107patient 135, normal, homogenized [OPG study]5.2618546
GSM549115patient 068, normal, homogenized [OPG study]5.2387446
GSM549116patient 072, normal, homogenized [OPG study]5.2742746
GSM549120patient 078, normal, homogenized [OPG study]5.3122646
GSM549131patient 030, cancer, homogenized [OPG study]5.3201647
GSM549118patient 074, normal, homogenized [OPG study]5.3131246
GSM549129patient 027, cancer, homogenized [OPG study]5.3047646
GSM549123patient 088, normal, homogenized [OPG study]5.0715542
GSM549124patient 006, cancer, homogenized [OPG study]5.4769949
GSM549126patient 015, cancer, homogenized [OPG study]5.2497845
GSM549128patient 025, cancer, homogenized [OPG study]5.3141747
GSM549103patient 117, normal, homogenized [OPG study]5.4151747
GSM549117patient 073, normal, homogenized [OPG study]5.4356549
GSM549138patient 041, cancer, homogenized [OPG study]5.3713848
GSM549141patient 045, cancer, homogenized [OPG study]5.1522344
GSM549130patient 028, cancer, homogenized [OPG study]5.2295345
GSM549101patient 111, normal, homogenized [OPG study]5.0961341
GSM549105patient 128, normal, homogenized [OPG study]5.4749849
GSM549106patient 134, normal, homogenized [OPG study]5.2509346
GSM549112patient 048, normal, homogenized [OPG study]5.3522747
GSM549125patient 011, cancer, homogenized [OPG study]5.4382448
GSM549127patient 024, cancer, homogenized [OPG study]5.2609745
GSM549135patient 035, cancer, homogenized [OPG study]5.4188849